Iterum Therapeutics plc (ITRMF) Shareholders’ equity 2016–2021
Iterum Therapeutics plc (ITRMF) shareholders’ equity at each fiscal year-end, per SEC filings.
$50.2MFY2021 · since FY2016: $22.7M → $50.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $50.2M | +199.4% |
| FY2020 | -$50.6M | -92.7% |
| FY2019 | -$26.2M | -136.6% |
| FY2018 | $71.6M | +81.3% |
| FY2017 | $39.5M | +74.2% |
| FY2016 | $22.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice